Levetiracetam as a possible cause of fulminant liver failure

被引:25
作者
Tan, T. C. H. [1 ]
de Boer, B. W. [3 ]
Mitchell, A. [2 ]
Delriviere, L. [2 ]
Adams, L. A. [1 ,4 ]
Jeffrey, G. P. [1 ,2 ]
MacQuillan, G. [1 ,4 ]
机构
[1] Sir Charles Gairdner Hosp, Dept Gastroenterol & Hepatol, Nedlands, WA 6008, Australia
[2] Sir Charles Gairdner Hosp, WA Liver & Kidney Transplant Serv, Nedlands, WA 6008, Australia
[3] Queen Elizabeth II Med Ctr, Div Tissue Pathol, Nedlands, WA, Australia
[4] Univ Western Australia, Dept Med, Nedlands, WA 6009, Australia
关键词
D O I
10.1212/01.wnl.0000324604.11657.c6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:685 / 686
页数:2
相关论文
共 5 条
[1]   Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy [J].
Ben-Menachem, E ;
Gilland, E .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2003, 12 (03) :131-135
[2]   Pharmacokinetic profile of levetiracetam: toward ideal characteristics [J].
Patsalos, PN .
PHARMACOLOGY & THERAPEUTICS, 2000, 85 (02) :77-85
[3]   Clinical pharmacokinetics of levetiracetam [J].
Patsalos, PN .
CLINICAL PHARMACOKINETICS, 2004, 43 (11) :707-724
[4]   Pharmacokinetics of levetiracetam [J].
Radtke, RA .
EPILEPSIA, 2001, 42 :24-27
[5]  
Skopp Gisela, 2006, Archiv fuer Kriminologie, V217, P161